Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) — Announcement | 25 September 2026
Jagsonpal Pharmaceuticals has closed its insider trading window effective October 1, 2026, ahead of upcoming unaudited financial results for the quarter and six months ending September 30, 2026, with the board meeting date to be announced later.
About Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when JAGSNPHARM files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track JAGSNPHARM — Free💡 Ask AI about this filing
📊 More JAGSNPHARM filings
- 🔴 Corporate Action — 30 September 2026Jagsonpal Pharmaceuticals announced the allotment of 1,01,825 equity shares of Rs. 2 each under its ...
- 🔴 Announcement — 23 September 2026Jagsonpal Pharmaceuticals announced on September 23, 2026, that it has entered into a Business Trans...
- 🔴 Corporate Action — 23 September 2026Jagsonpal Pharmaceuticals announced on September 23, 2026, its agreement to acquire the Wellness Por...
- 🟡 Voting Results — 21 September 2026Jagsonpal Pharmaceuticals held its 47th AGM on September 18, 2026 via video conferencing, with votin...
- 🟡 Board Meeting — 18 September 2026Jagsonpal Pharmaceuticals held its 47th AGM on September 18, 2026 via video conference, electing Man...
🔥 Also filed on 25 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when JAGSNPHARM files new disclosures
Track JAGSNPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track JAGSNPHARM — FreeFree account · 2 AI queries/day